Ibuprofen; no evidence preventing use during COVID-19

The updated position from the National Health Services (NHS), Medicines & Healthcare Products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) confirms that patients can take ibuprofen when self-medicating for symptoms of COVID-19, such as fever and headache.

• Full supporting Commission of Human Medicines (CHM) statement available
• Full MHRA, NHS and NICE letter available

Ibuprofen is a well-established medicine with a good safety profile that has been used as a self-care fever and pain reducer for more than 30 years.

We will of course be reviewing and looking-out for any new evidence that is published and letting pharmacists and their teams know if things change.